EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis

Andrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, Gabriele Missale, Francesco Giuseppe Foschi, Fabio Piscaglia, Sara Boninsegna, Andrea Mega, Nora Cazzagon, Filippo Pelizzaro, Mauro Viganò, Franco Trevisani und 21 weitere

Digestive Diseases and Sciences · 2025

DOI: 10.1007/s10620-025-09064-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Diseases and Sciences, 2025. Verfasst von Andrea Pasta und 32 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, No. 6, 16132, Genoa, Italy. Hauptthemen laut MEDLINE: Hepatitis, Autoimmune, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Genova.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The incidence of HCC in patients with autoimmune hepatitis (AIH) is low and, due to the paucity of data in the literature, a thorough characterization of these patients is missing. AIM: To describe the main characteristics and outcome of patients with AIH and HCC. METHODS: Among patients with HCC included in the Italian Liver Cancer (ITA.LI.CA) database during the period 2009-2022, we selected those with AIH, and we described their liver disease characteristics, modality of HCC diagnosis, tumor stage, treatment, and outcome. RESULTS: Among 10,026 patients with HCC, we identified 23 patients (0.2%) with AIH (43.5% males, 69.6% aged > 65 years, 91.0% with cirrhosis). Fifteen patients (65.2%) had co-factors of liver disease [8 patients (34.8%) metabolic dysfunction-associated steatotic liver disease, 4 patients (17.4%) alcohol abuse, 3 patients (13.0%) AIH/Primary Biliary Cholangitis overlap syndrome]. Tumors diagnosed under surveillance (60.9%) were more frequently uninodular (85.7% vs 66.6%, p = 0.146) and Milan-in (85.7% vs 44.4%, p = 0.066) than those diagnosed outside surveillance. Treatment with curative intent was more frequent among patients under surveillance (78.6% vs 33.3%, p = 0.077). Median overall survival was 41.7 months and was remarkably longer in patients under surveillance than in those diagnosed outside surveillance (68.2 vs 27.4 months, p = 0.032). CONCLUSION: AIH accounts for a minimal fraction of patients with HCC, and in most patients, risk co-factors for HCC are present. In patients with AIH, too, surveillance is associated with better tumor stage, higher access rate to potentially curative treatments, and improved survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis, AutoimmuneCarcinoma, HepatocellularLiver NeoplasmsHumansMaleFemaleAgedMiddle AgedItalyRetrospective StudiesTreatment OutcomeAdultRisk Factors

Stichwörter der Autor:innen

Autoimmune hepatitisOncological outcomesRisk stratificationSurveillance

Autor:innen und Institutionen

  • Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Viale Benedetto XV, No. 6, 16132, Genoa, Italy.
  • Gastroenterology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Department of Medicine and Surgery, Infectious Diseases and Hepatology Unit, University of Parma and Azienda Ospedaliero-Universitaria of Parma, Parma, Italy.
  • Department of Internal Medicine, Ospedale per gli Infermi di Faenza, Faenza, Italy.
  • Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Förderung

  • Università degli Studi di Genova

Zitieren

APA

Pasta, A., Pieri, G., Plaz Torres, M. C., Missale, G., Foschi, F. G., Piscaglia, F., Boninsegna, S., Mega, A., Cazzagon, N., Pelizzaro, F., Viganò, M., Trevisani, F., Bucci, L., Azzaroli, F., Brunetto, M. R., Campani, C., Celsa, C., Ghittoni, G., Magalotti, D., …, & Italian Liver Cancer (ITA.LI.CA) Group (2025). Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-025-09064-1

Vancouver

Pasta A, Pieri G, Plaz Torres MC, Missale G, Foschi FG, Piscaglia F, et al. Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences. 2025. doi:10.1007/s10620-025-09064-1

BibTeX
@article{Pasta2025,
  author = {Pasta, Andrea and Pieri, Giulia and Plaz Torres, Maria Corina and Missale, Gabriele and Foschi, Francesco Giuseppe and Piscaglia, Fabio and Boninsegna, Sara and Mega, Andrea and Cazzagon, Nora and Pelizzaro, Filippo and Viganò, Mauro and Trevisani, Franco and Bucci, Laura and Azzaroli, Francesco and Brunetto, Maurizia Rossana and Campani, Claudia and Celsa, Ciro and Ghittoni, Giorgia and Magalotti, Donatella and Martini, Andrea and Morisco, Filomena and Nardone, Gerardo and Ponziani, Francesca Romana and Sacco, Rodolfo and Sacerdoti, David and Saitta, Carlo and Sangiovanni, Angelo and Lani, Lorenzo and Svegliati-Baroni, Gianluca and Vidili, Gianpaolo and Vitale, Alessandro and Giannini, Edoardo G and Italian Liver Cancer (ITA.LI.CA) Group, Italian Liver Cancer (ITA.LI.CA) Group},
  title = {Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis},
  journal = {Digestive Diseases and Sciences},
  year = {2025},
  doi = {10.1007/s10620-025-09064-1}
}
Kostenlos starten →